Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 263 (RN7SKP263) is a non-coding RNA pseudogene located on chromosome 12 (chr12:94008739-94009047, hg38)[2]. It is classified as a pseudogene of the 7SK small nuclear RNA, meaning it shares sequence similarity with the functional 7SK RNA but does not produce a functional molecule. The functional 7SK small nuclear RNA regulates RNA polymerase II transcription elongation and various nuclear processes, but the RN7SKP263 pseudogene itself is not involved in these biological functions nor is it recognized as a drug target[1][2]. RN7SKP263 is not a receptor, enzyme, transporter, or other therapeutic target class; it exists only as a genomic locus regarded as a pseudogene (non-functional copy) of RN7SK[2]. For structured information about the functional RN7SK small nuclear RNA, refer to 7SK small nuclear RNA instead[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 263 (RN7SKP263).